These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9458995)

  • 1. Management of problematic behavioral symptoms associated with dementia: a cognitive developmental approach.
    Matteson MA; Linton AD; Cleary BL; Barnes SJ; Lichtenstein MJ
    Aging (Milano); 1997 Oct; 9(5):342-55. PubMed ID: 9458995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer dementia: Starting, stopping drug therapy.
    Kim LD; Factora RM
    Cleve Clin J Med; 2018 Mar; 85(3):209-214. PubMed ID: 29522388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Effects of Activities, Social Environment, and Psychotropic Medication Use on Behavioral Symptoms of Individuals With Alzheimer's Disease in Nursing Homes.
    Inventor BR; Farran CJ; Paun O; Cothran F; Rajan K; Swantek SS; McCann JJ
    J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):18-26. PubMed ID: 29741750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings.
    Gustafsson M; Sandman PO; Karlsson S; Gustafson Y; Lövheim H
    Int Psychogeriatr; 2013 Sep; 25(9):1415-23. PubMed ID: 23782794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia.
    Nijk RM; Zuidema SU; Koopmans RT
    Int Psychogeriatr; 2009 Jun; 21(3):485-93. PubMed ID: 19368752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in psychotropic drug use in Norwegian nursing homes between 2004 and 2011.
    Selbæk G; Janus SIM; Bergh S; Engedal K; Ruths S; Helvik AS; Šaltyte Benth J; Zuidema SU
    Int Psychogeriatr; 2018 Mar; 30(3):385-394. PubMed ID: 28988552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
    J Neurol Sci; 2014 Jan; 336(1-2):103-8. PubMed ID: 24189208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.
    Gustafsson M; Isaksson U; Karlsson S; Sandman PO; Lövheim H
    Eur J Clin Pharmacol; 2016 Aug; 72(8):987-94. PubMed ID: 27071994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior as an efficacy outcome.
    Cummings JL
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():v-vi. PubMed ID: 9339265
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychiatric and behavioural symptoms and the use of psychotropic medication in Special Care Units and Regular Units in Norwegian nursing homes.
    Selbaek G; Kirkevold Ø; Engedal K
    Scand J Caring Sci; 2008 Dec; 22(4):568-73. PubMed ID: 18801019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial and long-term evaluation of patients with Alzheimer's after hospitalization in cognitive and behavioural units: the EVITAL study design.
    Pongan E; Freulon M; Delphin-Combe F; Dibie-Racoupeau F; Martin-Gaujard G; Federico D; Waissi A; Richard G; Jacqueline S; Fabre F; Trombert-Paviot B; Krolak-Salmon P; Laurent B; Rouch I
    BMC Psychiatry; 2014 Nov; 14():308. PubMed ID: 25398578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease.
    Lavretsky H; Nguyen LH
    Psychiatr Serv; 2006 May; 57(5):617-9. PubMed ID: 16675752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special care units for persons with dementia: expected and observed effects on behavioral symptoms.
    Maslow K
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 3():122-37. PubMed ID: 7999339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.
    Bodick NC; Offen WW; Shannon HE; Satterwhite J; Lucas R; van Lier R; Paul SM
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S16-22. PubMed ID: 9339268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes between 1982 and 2000 in the prevalence of behavioral symptoms and psychotropic drug treatment among old people with cognitive impairment in geriatric care.
    Lövheim H; Sandman PO; Karlsson S; Gustafson Y
    Int Psychogeriatr; 2009 Oct; 21(5):941-8. PubMed ID: 19586566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease.
    Francis PT
    Neurodegener Dis; 2008; 5(3-4):241-3. PubMed ID: 18322401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of TimeSlips creative expression program on behavioral symptoms and psychotropic medication use in persons with dementia in long-term care: a cluster-randomized pilot study.
    Houser WS; George DR; Chinchilli VM
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):337-40. PubMed ID: 23602304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of behavioral disturbances and pattern of psychotropic medication use in five skilled nursing facilities.
    Ramadan FH; Naughton BJ; Prior R
    J Geriatr Psychiatry Neurol; 2003 Mar; 16(1):8-14. PubMed ID: 12641366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.